NXP-900

· Nuvectis Pharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NXP-900, covering 2026-03-03 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers [Phase 1]